UK Judge Rules J&J Alzheimer Patent Invalid

Law360, New York (June 25, 2013, 6:47 PM EDT) -- A U.K. judge has ruled that a patent held by a Johnson & Johnson unit that is related to a potential treatment for Alzheimer's disease is invalid, siding with pharmaceutical maker Eli Lilly & Co., which challenged the patent, officials confirmed.

Judge Richard Arnold deemed the patent held by J&J's Janssen Alzheimer Immunotherapy Research & Development LLC invalid, according to a Bloomberg report published Tuesday. A copy of Judge Arnold's decision was not immediately available.

“We are disappointed by the outcome of this case, and we...
To view the full article, register now.

UK Financial Services

UK Financial Services

Read Our Latest UK Financial Services Coverage

Financial Services Law360 UK provides breaking news and analysis on the financial sector. Coverage includes UK and European Union policy, enforcement, and litigation involving banks, asset management firms, and other financial services organizations.